- ISIN
- US04546C2052
- CUSIP
- 04546C205
- Delisting Date
- Jun 16, 2026
- Sector
- Healthcare
- IPO Date
- Nov 5, 1997
Highlights
- Market Cap
- $151.20M
- Enterprise Value
- $156.74M
- EPS (TTM)
- -$5.27
- Total Revenue (TTM)
- $102.16M
- Gross Profit (TTM)
- $71.85M
- EBITDA (TTM)
- -$2.31M
- Year Range
- $8.61 - $23.50
- Target Price
- $19.90
- ROA (TTM)
- -16.44%
- ROE (TTM)
- -45.92%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ASRT Performance Chart
Loading charts...
Compare this symbol against anything
Returns By Period
Assertio Holdings, Inc.
- 1D
- —
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
ASRT Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 29.88% | -1.02% | 63.46% | -3.31% | 27.18% | 0.26% | 159.10% | ||||||
| 2025 | -7.86% | -3.33% | -13.06% | -3.71% | 2.26% | -3.48% | 11.67% | 16.63% | 5.47% | -15.49% | -1.26% | -17.73% | -30.59% |
| 2024 | -17.51% | 0.15% | 8.53% | -7.73% | 12.39% | 24.65% | 12.10% | -15.11% | -0.00% | -12.71% | -2.91% | -12.89% | -18.59% |
| 2023 | -4.42% | 34.55% | 15.19% | -13.50% | 14.88% | -14.38% | 4.98% | -42.36% | -21.95% | -16.02% | -52.56% | 4.90% | -75.12% |
| 2022 | 18.81% | -11.20% | 24.78% | -26.48% | 42.65% | -1.99% | 32.20% | -34.62% | -10.98% | 13.66% | 20.16% | 38.71% | 97.25% |
| 2021 | 76.31% | 35.29% | -19.99% | -19.40% | -17.74% | -13.81% | -19.23% | -15.08% | -15.33% | 13.69% | 37.86% | 53.52% | 52.40% |
Benchmark Metrics
Assertio Holdings, Inc. has an annualized alpha of 3.66%, beta of 1.19, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since December 17, 2003.
- This stock participated in 162.31% of S&P 500 Index downside but only 69.66% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 3.66%
- Beta
- 1.19
- R²
- 0.09
- Upside Capture
- 69.66%
- Downside Capture
- 162.31%
Return for Risk
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Assertio Holdings, Inc. (ASRT) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASRT | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.25 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.00 | — |
| Martin ratioReturn relative to average drawdown | — | 8.49 | — |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Assertio Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Assertio Holdings, Inc. was 99.60%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.60%Apr 2025 | 9y 8mo | — | 11y 14dJul 2015 - now | 2025 selloff2025 |
-88.50%Nov 2008 | 4y 6mo | 2y 2mo | 6y 9moApr 2004 - Feb 2011 | Financial crisis2007–2009 |
-57.57%Nov 2011 | 7mo 26d | 2y 28d | 2y 8moApr 2011 - Dec 2013 | — |
-34.24%Jul 2014 | 4mo 12d | 27d | 5mo 9dMar 2014 - Aug 2014 | — |
-28.02%May 2015 | 16d | 1mo 25d | 2mo 11dApr 2015 - Jul 2015 | — |
Drawdown Indicators
| ASRT | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | -1.58% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.70% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.14% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Assertio Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Assertio Holdings, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ASRT relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ASRT has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ASRT in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ASRT has a P/B value of 2.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ASRT
Add Assertio Holdings, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ASRT